Tolterodine Tartrate NDC 71205-319

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-319Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0319Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-319-30	71205031930	30 TABLET, FILM COATED in 1 BOTTLE (71205-319-30)Marketed from Sep 1, 2019
71205-319-60	71205031960	60 TABLET, FILM COATED in 1 BOTTLE (71205-319-60)Marketed from Sep 1, 2019
71205-319-90	71205031990	90 TABLET, FILM COATED in 1 BOTTLE (71205-319-90)Marketed from Sep 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolterodine Tartrate
Generic name (nonproprietary): tolterodine tartrate
Active ingredients: Tolterodine tartrate — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077006
Marketing start: Nov 1, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 71205-319_df5371c1-a1d3-4e6d-af7a-17cb46d7653dSPL ID df5371c1-a1d3-4e6d-af7a-17cb46d7653dSPL set ID b77f9893-a422-423a-bb27-527377ade36dRxCUI 855178UNII 5T619TQR3R
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205031930 followed by a unit qualifier and the quantity

Package 71205-0319-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Tolterodine tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077006

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077006
Product	Strength	Form · route	Labeler	Product NDC
Tolterodine Tartrate	Tolterodine tartrate 1 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-0010
Tolterodine Tartrate	Tolterodine tartrate 2 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-0018